Top Industry Lists Archives

Latest stories

7 Shares

TOP 100 HEALTHCARE COMPANIES

5 Shares

TOP 50 PHARMA COMPANIES

10 Shares

TOP 50 MEDICAL DEVICE COMPANIES

2 Shares

TOP 50 BIOTECH COMPANIES

Trending Now

104 Views0 Comments
in Headlines

Novartis has acquired global development and commercial rights to therapeutic applications for iTheranostics’ library of FAP-targeted drugs

Culver City, CA, March 30, 2021 (PRNewswire) — SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, has executed an assignment agreement that provides exclusive rights to Novartis to develop therapeutic applications for a library of FAP-targeted agents. SOFIE may facilitate clinical supply and is responsible for the commercialization of FAP-targeted PET imaging tracers globally. More

by hsandm March 30, 2021, 7:02 pm

Read More
102 Views0 Comments
in Headlines

Omega Therapeutics to Advance Pipeline and Platform Development with $126 Million in Additional Financing

Cambridge, MA., March 30, 2021 (PRNewswire) — Omega Therapeutics, Inc. (“Omega”), a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, today announced the closing of an upsized Series C financing of $126 million. Joining Flagship Pioneering, Omega’s institutional founder and principal backer, are leading life science investors including Invus, Fidelity Management & Research Company, funds and accounts managed by BlackRock, Cowen, Point72, Logos Capital, Mirae Asset Capital and other undisclosed new and returning institutional investors. With this financing, Omega has raised over $210 million since its founding in 2017. More

by hsandm March 30, 2021, 3:19 pm

Read More
251 Views0 Comments
in Headlines

Charles River Laboratories Completes the Acquisition of Cognate BioServices

Wilmington, MA., March 29 2021 (BUSINESS WIRE) — Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Cognate BioServices, Inc. for approximately $875 million, subject to customary closing adjustments. More

by hsandm March 29, 2021, 9:09 pm

Read More
725 Views0 Comments
in Headlines

Philips sells appliances arm to China’s Hillhouse for €4.37 billion

Amsterdam, the Netherlands, March 25 2021 (Globe Newswire) – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to sell its Domestic Appliances business, a global leader with EUR 2.2 billion sales in 2020 in kitchen, coffee, garment care and home care appliances, to Hillhouse Capital, a global investment firm focused on helping companies achieve long-term sustainable growth through digital innovation and enablement. The transaction is expected to be completed in the third quarter of 2021, subject to customary closing conditions, including the relevant regulatory approvals. More

by hsandm March 25, 2021, 12:44 am

Read More
533 Views0 Comments
in Headlines

RiverVest Venture Partners Closes $275 Million Life Sciences Fund

St. Louis, MO, March 24 2021, (Business Wire) — RiverVest Venture Partners, a leading venture capital firm, announced today the closing of its RiverVest Venture Fund V, L.P. (“Fund V”), with $275 million of capital commitments in an oversubscribed fundraise. Fund V brings the firm’s total assets under management to more than $1.6 billion. More

by hsandm March 24, 2021, 11:23 pm

Read More
934 Views0 Comments
in Headlines

Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.

Philadelphia and New York, March 23, 2021 (PRNewswire) — Renovacor, Inc. (“Renovacor” or the “Company”), an early-stage biotechnology company developing AAV-based gene therapies for devastating cardiovascular and central nervous system (CNS) diseases resulting from BAG3 gene dysfunction, and Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) (“CHAQ”), a special purpose acquisition company or SPAC, sponsored by affiliates of Chardan Capital Markets (“Chardan”), announced today they have entered into a definitive business combination agreement. Upon closing of the transaction, CHAQ will be renamed Renovacor, Inc. and its common stock is expected to be listed on NYSE under the ticker symbol “RCOR” (the “Combined Company”). More

by hsandm March 23, 2021, 12:32 am

Read More

Top Industry Lists

Latest stories

TOP 100 HEALTHCARE COMPANIES

TOP 50 PHARMA COMPANIES

TOP 50 MEDICAL DEVICE COMPANIES

TOP 50 BIOTECH COMPANIES

More stories

TOP 100 HEALTHCARE COMPANIES

MEDICAL DEVICE TOP 50

TOP 100 HEALTHCARE COMPANIES

MEDICAL DEVICE TOP 50

HS&M TOP LISTS

REVENUES CONTINUE TO RISE: THE TOP 50 PHARMA COMPANIES

BIOTECH IPOS DOUBLE, REVENUES UP 9%: THE TOP 50

HS&M TOP LISTS

TOP 100 HEALTHCARE COMPANIES

Revenue on the Rise:The Top 50 Pharma Companies

BIOTECH IPOS UP, MARKET DOWN, REVENUES FLAT: THE TOP 50

TOP LISTS the publication for healthcare sales & marketing leaders ™

Novartis has acquired global development and commercial rights to therapeutic applications for iTheranostics’ library of FAP-targeted drugs

Omega Therapeutics to Advance Pipeline and Platform Development with $126 Million in Additional Financing

Charles River Laboratories Completes the Acquisition of Cognate BioServices

Philips sells appliances arm to China’s Hillhouse for €4.37 billion

RiverVest Venture Partners Closes $275 Million Life Sciences Fund

Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.

Latest stories

More stories

Log In

Sign In

Forgot password?

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections